Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: Do we still need a second GH stimulation test?

Clinical Endocrinology

Volumn 57, Issue 2, 2002, Pages 161-167

  Cianfarani, Stefano ^a,c   Tondinelli, Tiziana ^a   Spadoni, Gian Luigi ^a   Scirè, Giuseppe ^a   Boemi, Sergio ^b   Boscherini, Brunetto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CLONIDINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONE SUBSTITUTION; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROVOCATION TEST; RETROSPECTIVE STUDY; SHORT STATURE;

ARGININE; BODY HEIGHT; CHILD; CLONIDINE; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; IMMUNORADIOMETRIC ASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STIMULATION, CHEMICAL;

EID: 0036375589     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01591.x     Document Type: Article

References (40)

1. Circulating binding proteins for the insulin-like growth factors
2. Overview of the National Cooperative Growth Study substudy of serial growth hormone measurements
3. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
4. Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: Suggestions for new diagnostic criteria
5. Pitfalls in diagnosing impaired growth hormone (GH) secretion: Retesting after replacement therapy of 63 patients defined as GH deficient
6. Somatomedin binding proteins: What role do they play in the growth process?
7. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency?
8. Abnormal growth velocity does not impair the attainment of target height in 'small-delay' children
9. Growth hormone state after completion of treatment with growth hormone
10. Growth hormone therapy for 3 years: The OZGROW experience
11. Cross sectional stature and weight reference curves for the UK
12. Reliability of provocative tests to assess growth hormone secretory status, Study in 472 normally growing children
13. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society
14. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: Importance of an appropriate reference population
15. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency
16. The role of auxologic and growth factor measurements in the diagnosis of growth hormone deficiency
17. Growth deceleration patterns in constitutional short stature. An aid to diagnosis
18. Insulin-like growth factors and their binding proteins
19. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3
20. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities
21. Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency
22. Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents
23. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood
24. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children-a clinical research centre study
25. Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children
26. Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children
27. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency
28. Is growth hormone deficiency a viable diagnosis?
29. Insulin-like growth factors I and II in evaluation of growth retardation
30. The diagnosis of growth hormone deficiency in children and adults
31. Efficacy of insulin-like growth factor binding protein 3 ion predicting the growth response to provocative testing in children treated with cranial irradiation
32. Use of insulin-like growth factor-binding protein-3 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children
33. Characterisation of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kDa) in urine and serum from healthy children and growth hormone deficient patients: Relationship with GH therapy
34. Growth hormone neurosecretory dysfunction. A treatable cause of short stature
35. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty
36. Biochemical tests in the diagnosis of childhood growth hormone deficiency
37. The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study)
38. Growth hormone measurements versus auxology in treatment decisions: The Australian experience